Jun 28, 2022

Featuring perspectives from Drs Javier Cortés, Matthew Goetz, Erika Hamilton, Ian Krop, Hope Rugo and Sara Tolaney, including the following topics:

• Introduction (0:00)
• Optimizing the Management of ER-Positive Localized Breast Cancer — Matthew P Goetz, MD (7:50)
• New and Novel Treatment Strategies for...

May 17, 2022

Featuring perspectives from Ms Jamie Carroll, Dr Sara Hurvitz, Ms Kelly Leonard and Dr Hope Rugo, including the following topics:

• Introduction (0:00)
• High-Risk Localized ER-Positive, HER2-Negative Breast Cancer (5:07)
• ER-Positive Metastatic Breast Cancer (28:06)
• Localized HER2-Positive Breast Cancer (49:15)
• Metastatic...

Apr 20, 2022

Featuring a slide presentation and related discussion from Dr Judy Garber, including the following topics:

• PARP Inhibitors in Breast Cancer (0:00)
• OlympiA and NEOTALA Trials (12:03)
• Emerging Strategies with PARP Inhibitors in Breast Cancer (20:08)

CME information and select...

Apr 20, 2022

Featuring an interview with Dr Judy Garber, including the following topics:

• Applying the FDA indications for PARP inhibitors in breast cancer (0:00)
• Role of HRD (homologous recombination deficiency) and loss of heterozygosity in assessing patient risk; potential role for PARP inhibitors and other therapies for patients...

Mar 16, 2022

The Great Adjuvant Debate — Exploring the Role of Novel Therapies in the Management of Localized Cancer — Faculty Presentation 3: Optimal Integration of Novel Therapies in the Management of Localized Breast Cancer — Dr Sara Tolaney

CME information and select...